Silvia C. Formenti

43.0k total citations · 20 hit papers
348 papers, 27.2k citations indexed

About

Silvia C. Formenti is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Silvia C. Formenti has authored 348 papers receiving a total of 27.2k indexed citations (citations by other indexed papers that have themselves been cited), including 186 papers in Oncology, 99 papers in Immunology and 98 papers in Cancer Research. Recurrent topics in Silvia C. Formenti's work include Cancer Immunotherapy and Biomarkers (107 papers), Immunotherapy and Immune Responses (82 papers) and Breast Cancer Treatment Studies (73 papers). Silvia C. Formenti is often cited by papers focused on Cancer Immunotherapy and Biomarkers (107 papers), Immunotherapy and Immune Responses (82 papers) and Breast Cancer Treatment Studies (73 papers). Silvia C. Formenti collaborates with scholars based in United States, Italy and France. Silvia C. Formenti's co-authors include Sandra Demaria, James S. Babb, Robert J. Schneider, Claire Vanpouille‐Box, Encouse B. Golden, Noriko Kawashima, J. Keith DeWyngaert, M. Devitt, C. Norman Coleman and Lorenzo Galluzzi and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Silvia C. Formenti

337 papers receiving 26.8k citations

Hit Papers

Fractionated but Not Sing... 2001 2026 2009 2017 2009 2017 2004 2018 2013 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody
    2009 1.3k citations Md. Zahidunnabi Dewan, Noriko Kawashima et al. Clinical Cancer Research profile →
  2. DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
    2017 1.2k citations Claire Vanpouille‐Box, Yasmeen Sarfraz et al. profile →
  3. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
    2004 1.1k citations Sandra Demaria, M. Devitt et al. International Journal of Radiation Oncology*Biology*Physics profile →
  4. Using immunotherapy to boost the abscopal effect
    2018 891 citations Sandra Demaria, Silvia C. Formenti et al. profile →
  5. Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
    2013 819 citations Silvia C. Formenti, Sandra Demaria profile →
  6. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
    2017 811 citations Silvia C. Formenti, Percy Lee et al. profile →
  7. Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
    2005 787 citations Sandra Demaria, Noriko Kawashima et al. Clinical Cancer Research profile →
  8. Systemic effects of local radiotherapy
    2009 776 citations Silvia C. Formenti, Sandra Demaria profile →
  9. Translational control in cancer
    2010 645 citations Silvia C. Formenti, Robert J. Schneider et al. profile →
  10. Radiotherapy induces responses of lung cancer to CTLA-4 blockade
    2018 640 citations Silvia C. Formenti, Nils-Petter Rudqvist et al. profile →
  11. Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
    2001 616 citations Silvia C. Formenti et al. profile →
  12. Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells
    2008 567 citations Noriko Kawashima, James S. Babb et al. profile →
  13. Role of Local Radiation Therapy in Cancer Immunotherapy
    2015 537 citations Sandra Demaria, Encouse B. Golden et al. profile →
  14. An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer
    2013 529 citations Encouse B. Golden, Sandra Demaria et al. Cancer Immunology Research profile →
  15. Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
    2015 505 citations Encouse B. Golden, Sylvia Adams et al. profile →
  16. Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
    2014 469 citations Encouse B. Golden, Sandra Demaria et al. profile →
  17. TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity
    2015 413 citations Claire Vanpouille‐Box, Julie M. Diamond et al. Cancer Research profile →
  18. Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect
    2018 356 citations Claire Vanpouille‐Box, Silvia C. Formenti et al. profile →
  19. Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
    2021 210 citations Silvia C. Formenti et al. profile →
  20. Emerging evidence for adapting radiotherapy to immunotherapy
    2023 191 citations Lorenzo Galluzzi, Silvia C. Formenti et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia C. Formenti United States 79 15.6k 9.8k 6.5k 5.1k 4.5k 348 27.2k
Sandra Demaria United States 65 14.7k 0.9× 10.6k 1.1× 4.8k 0.7× 3.6k 0.7× 2.3k 0.5× 192 21.7k
Robert L. Ferris United States 90 13.5k 0.9× 7.6k 0.8× 4.8k 0.7× 6.6k 1.3× 3.6k 0.8× 556 28.7k
Quynh‐Thu Le United States 79 7.8k 0.5× 2.0k 0.2× 7.0k 1.1× 6.7k 1.3× 5.2k 1.2× 461 25.4k
Timothy A. Chan United States 77 10.4k 0.7× 4.5k 0.5× 5.5k 0.9× 9.4k 1.8× 5.2k 1.2× 243 22.7k
William H. McBride United States 66 6.6k 0.4× 5.3k 0.5× 2.8k 0.4× 5.7k 1.1× 2.1k 0.5× 305 17.1k
Cornelis J.A. Punt Netherlands 73 16.6k 1.1× 5.6k 0.6× 4.5k 0.7× 5.6k 1.1× 3.9k 0.9× 392 24.3k
Armando Santoro Italy 87 17.8k 1.1× 2.5k 0.3× 13.8k 2.1× 5.6k 1.1× 3.8k 0.9× 924 34.7k
Henry S. Friedman United States 95 9.0k 0.6× 4.2k 0.4× 7.9k 1.2× 15.0k 2.9× 7.5k 1.7× 567 38.4k
Paul A. Bunn United States 96 16.9k 1.1× 7.1k 0.7× 14.6k 2.3× 9.9k 1.9× 4.0k 0.9× 496 35.3k
Jack A. Roth United States 97 12.9k 0.8× 2.6k 0.3× 16.3k 2.5× 13.4k 2.6× 4.3k 1.0× 661 36.5k

Countries citing papers authored by Silvia C. Formenti

Since Specialization
Citations

This map shows the geographic impact of Silvia C. Formenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia C. Formenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia C. Formenti more than expected).

Fields of papers citing papers by Silvia C. Formenti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia C. Formenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia C. Formenti. The network helps show where Silvia C. Formenti may publish in the future.

Co-authorship network of co-authors of Silvia C. Formenti

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia C. Formenti. A scholar is included among the top collaborators of Silvia C. Formenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia C. Formenti. Silvia C. Formenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Racine‐Brzostek, Sabrina, Jim Yee, Ashley Sukhu, et al.. (2021). Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals. JCI Insight. 6(20). 16 indexed citations
2.
Petroni, Giulia, Aitziber Buqué, Takahiro Yamazaki, et al.. (2021). Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer. Clinical Cancer Research. 27(7). 1855–1863. 36 indexed citations
3.
Ascierto, Paolo A., Carlo Bifulco, Fortunato Ciardiello, et al.. (2021). Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy). Journal of Translational Medicine. 19(1). 238–238. 3 indexed citations
4.
Pilones, Karsten A., et al.. (2020). Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses. Cancer Immunology Research. 8(8). 1054–1063. 35 indexed citations
5.
Ko, Eric C. & Silvia C. Formenti. (2019). Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality. International Journal of Radiation Biology. 95(7). 936–939. 57 indexed citations
6.
Formenti, Silvia C., Percy Lee, Sylvia Adams, et al.. (2018). Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer. Clinical Cancer Research. 24(11). 2493–2504. 205 indexed citations
7.
Diamond, Julie M., Claire Vanpouille‐Box, Sheila Spada, et al.. (2018). Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs. Cancer Immunology Research. 6(8). 910–920. 283 indexed citations
8.
Rudqvist, Nils-Petter, Karsten A. Pilones, Claire Lhuillier, et al.. (2017). Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells. Cancer Immunology Research. 6(2). 139–150. 163 indexed citations
9.
Vanpouille‐Box, Claire, Julie M. Diamond, Karsten A. Pilones, et al.. (2015). TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity. Cancer Research. 75(11). 2232–2242. 413 indexed citations breakdown →
10.
Balogun, Onyinye & Silvia C. Formenti. (2015). Locally Advanced Breast Cancer – Strategies for Developing Nations. Frontiers in Oncology. 5. 89–89. 20 indexed citations
11.
Pola, Carolina, Silvia C. Formenti, & Robert J. Schneider. (2013). Vitronectin–αvβ3 Integrin Engagement Directs Hypoxia-Resistant mTOR Activity and Sustained Protein Synthesis Linked to Invasion by Breast Cancer Cells. Cancer Research. 73(14). 4571–4578. 41 indexed citations
12.
Adams, Sylvia, Lina Kozhaya, Frank Martiniuk, et al.. (2012). Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer. Clinical Cancer Research. 18(24). 6748–6757. 184 indexed citations
13.
Dewan, Md. Zahidunnabi, Claire Vanpouille‐Box, Noriko Kawashima, et al.. (2012). Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer. Clinical Cancer Research. 18(24). 6668–6678. 125 indexed citations
14.
Bauer, Joshua A., A. Bapsi Chakravarthy, Jennifer M. Rosenbluth, et al.. (2010). Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation. Clinical Cancer Research. 16(2). 681–690. 142 indexed citations
15.
Pilones, Karsten A., Noriko Kawashima, Anne Marie Yang, et al.. (2009). Invariant Natural Killer T Cells Regulate Breast Cancer Response to Radiation and CTLA-4 Blockade. Clinical Cancer Research. 15(2). 597–606. 88 indexed citations
16.
Jacoby, Steven C., Zhicheng Zhao, Zhiwei Yang, et al.. (2007). Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine. 177(1). 82–90. 226 indexed citations
17.
Ho, Alice Y., David P. Atencio, Sheila Annie Peters, et al.. (2006). Genetic Predictors of Adverse Radiotherapy Effects: The Gene-PARE project. International Journal of Radiation Oncology*Biology*Physics. 65(3). 646–655. 78 indexed citations
18.
Andreassen, Christian Nicolaj, Jens Overgaard, Jan Alsner, et al.. (2005). ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 64(3). 776–783. 76 indexed citations
19.
Formenti, Silvia C., Darcy Spicer, Kristin A. Skinner, et al.. (2002). Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer. International Journal of Radiation Oncology*Biology*Physics. 52(2). 397–405. 32 indexed citations
20.
Formenti, Silvia C., Parkash S. Gill, Mark U. Rarick, et al.. (1989). Primary central nervous system lymphoma in AIDS. Results of radiation therapy. Cancer. 63(6). 1101–1107. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra Demaria Breakdown of academic impact, for papers by Robert L. Ferris Breakdown of academic impact, for papers by Quynh‐Thu Le Breakdown of academic impact, for papers by Timothy A. Chan Breakdown of academic impact, for papers by William H. McBride Breakdown of academic impact, for papers by Cornelis J.A. Punt Breakdown of academic impact, for papers by Armando Santoro Breakdown of academic impact, for papers by Henry S. Friedman Breakdown of academic impact, for papers by Paul A. Bunn Breakdown of academic impact, for papers by Jack A. Roth
Rankless by CCL
2026